Comparison Between Late‑course Accelerated Hyperfractionation Radiotherapy and Concurrent Chemoradiotherapy in Patients With Esophageal Carcinoma

Oncology Letters - Greece
doi 10.3892/ol.2011.287
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Elective Lymph Node Irradiation Late Course Accelerated Hyper-Fractionated Radiotherapy Plus Concurrent Cisplatin-Based Chemotherapy for Esophageal Squamous Cell Carcinoma: A Phase II Study

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2013English

Neoadjuvant vs Definitive Concurrent Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma Patients

World Journal of Surgical Oncology
SurgeryOncology
2018English

Effectiveness of Esophagectomy in Patients With Thoracic Esophageal Squamous Cell Carcinoma Receiving Definitive Radiotherapy or Concurrent Chemoradiotherapy Through Intensity-Modulated Radiation Therapy Techniques

Cancer
Cancer ResearchOncology
2017English

Radiotherapy With Neoadjuvant Chemotherapy Versus Concurrent Chemoradiotherapy for Ascending-Type Nasopharyngeal Carcinoma: A Retrospective Comparison of Toxicity and Prognosis

Chinese Journal of Cancer
2017English

Feasibility and Efficiency of Concurrent Chemoradiotherapy With a Single Agent or Double Agents vs Radiotherapy Alone for Elderly Patients With Esophageal Squamous Cell Carcinoma: Experience of Two Centers

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Phase III Study of Cisplatin With Pemtrexed or Vinorelbine Plus Concurrent Late Course Accelerated Hyperfractionated Radiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer

Oncotarget
Oncology
2016English

Concurrent Chemoradiotherapy Using Paclitaxel Plus Cisplatin in the Treatment of Elderly Patients With Esophageal Cancer

OncoTargets and Therapy
OncologyPharmacology
2015English

Use CT Imaging to Predict the Short-Term Outcome of Concurrent Chemoradiotherapy in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma

Dose-Response
Chemical HealthMutagenesisPublic HealthEnvironmentalSafetyToxicologyHealthOccupational Health
2019English

Value and Application of Trimodality Therapy or Definitive Concurrent Chemoradiotherapy in Thoracic Esophageal Squamous Cell Carcinoma

Cancer
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy